Vistara Growth Leads US$25M Financing for VALD | Vistara Growth
Summary
Global health tech company VALD has closed a capital raise of approximately A$36m (US$25m) from leading North American investment firm Vistara Growth and Queensland Investment Corporation (QIC).VALDs range of human measurement technologies democratizes access to musculoskeletal technology to improve data-driven decision making. Over the past several years, the Company has brought their platform and expertise to healthcare practitioners, helping them improve outcomes for patients.VALD Co-founder and CEO, Mr. Laurie Malone, is confident the investment from Vistara Growth will provide strategic benefit in the North American market, where VALD products have seen the most adoption and generate over 50% of the Companys revenues.This partnership with Vistara Growth will accelerate our ongoing North American expansion and allow us to make further inroads into the healthcare market worldwide, Malone said. We are excited to back our first Australian-based company and see VALD as the world leader in their market, says Shipman.VALDs human measurement technology had been battle tested by the worlds most demanding customers in professional sport and defence organisations, Shipman continues, With rapid early adoption in healthcare settings, it was time to prepare for global expansion, and we are thrilled to be VALDs partner in driving this next phase of growth.Treasurer and Minister for Trade and Investment Cameron Dick said the funding would support VALDs latest $36 million capital raise, which includes North American investment firm Vistara Growth.The Queensland Government has been supporting VALD through our capital investment programs since the companys infancy, helping to accelerate its technology into a global success story, the Treasurer said.VALDs human measurement technologies are enabling the worlds best professional athletes to improve their performance by incorporating data-driven training and rehabilitation.Our support through the Queensland Investment Corporation-managed $100 million Business Investment Fund will assist VALDs rapid expansion into the health care sector.This will see VALD continue to expand its local team here in Brisbane, building their existing Queensland-based team which numbers over 120.VALDs global customer base includes renowned health providers like the Mayo Clinic in the US and leading European musculoskeletal facility. Peter Brem is the Senior Clinical Specialist of Physiotherapy at the latter, and uses VALD systems to capture accurate objective data.We use the data to generate immediate reports to our referrals, for instant and retrospective analysis of our rehabilitation protocols, and to conduct prospective clinical research, Brem said.Data captured through VALD allows us to remove subjectivity and determine the best treatment plan for our patients. This data allows us to create recovery plans that are unique in Switzerland and across mainland Europe he added.Musculoskeletal conditions are one of the largest burdens on health systems globally, representing an annual cost of $256 billion in the US alone.Our systems capture quantifiable objective data that help improve decision-making across a range of disciplines and provide deep, visualizable insights that save time and make it easier to analyse longitudinal trends across high-quality data points.MSK injuries are a systemic issue that places huge burdens on healthcare systems across the world, and were eager to apply VALDs technology to help alleviate these issues for our clients and their patients, VALDs chief executive Malone said.